**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

A 52-year-old man exhibited a lack of drug effect during treatment with levosimendan and norepinephrine for combined cardiogenic and vasoplegic shock.

The man presented in an emergency department with fever and dyspnea. His medical history included recent diagnosis of acute myocardial infarction (heart failure) with implantation of an implantable cardioverter defibrillator. Upon presentation at the emergency department (day 0), initial clinical presentation was considered as pulmonary congestion and acute on chronic heart failure. Then, he was transferred to the cardiology ward for further therapy. Upon transfer, he was on 3.0 L/min of oxygen without dyspnea. During the first night, a rapid increase in oxygen demand was noted. Therefore, in the early morning hour, he was shifted to an ICU for noninvasive ventilation for pulmonary congestion. On that day, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction test was found to be positive. Along with the development of acute respiratory distress syndrome, he developed combined cardiogenic and vasoplegic shock. Additionally, a reduced cardiac output was noted along with severe vasoplegia. Therefore, he started receiving norepinephrine and levosimendan \[*routes and dosages not stated*\]; however, the combined shock persisted. Further, an empiric off-label treatment for SARS-CoV-2 was initiated with lopinavir/ritonavir and chloroquine. The shock continued through day 2 and was further complicated by an acute kidney failure.

The man was successfully treated for cardiogenic shock with implantation of a peripheral ventricular assist device, and profound vasoplegic shock was successfully treated with venoarterial extracorporeal membrane oxygenation therapy. At the time of this report, he was undergoing treatment on day 24 of admission.
